Journals / Clinical and Experimental Health Sciences / 2020 / Cilt: 10 - Sayı: 3

Alterations in Enzyme Activity of Carbonic Anhydrase, 6-phosphogluconate Dehydrogenase and Thioredoxin Reduc- tase in Rats Exposed to Doxorubicin and Morin

Pages
228–234
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The findings showed that doxorubicin and morin had similar properties in the tissues as to their effect on enzyme activities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Carbonic anhydrase (CA), 6-phosphogluconate dehydrogenase (6PGD) and thioredoxin reductase (TrxR) enzymes are the essential biological molecules needed for metabolic processes in all living cells.
📊
Key Findings & Data:This study was designed to investigate the activities of CA, 6PGD and TrxR enzymes in the brain, kidney, liver, heart and testis tissues of the rats exposed to doxorubicin (DOX) and morin.
💡
Conclusion & Impact:Conclusion: The findings showed that doxorubicin and morin had similar properties in the tissues as to their effect on enzyme activities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Carbonic anhydrase (CA), 6-phosphogluconate dehydrogenase (6PGD) and thioredoxin reductase (TrxR) enzymes are the essential biological molecules needed for metabolic processes in all living cells. This study was designed to investigate the activities of CA, 6PGD and TrxR enzymes in the brain, kidney, liver, heart and testis tissues of the rats exposed to doxorubicin (DOX) and morin. Methods: Male Wistar albino rats were randomly divided into three groups as control, morin and DOX, each of them containing 7 rats. At the end of the experimental procedure, CA, 6PGD, and TrxR enzyme activities in tissues of rats were determined spectrophotometrically. Results: In our study, we observed that DOX activated CA enzyme in liver and kidney tissues while inhibiting CA enzyme in the other tissues, activated 6PGD enzyme in the kidney, liver and heart tissues, and inhibited the TrxR enzyme in all the tissues. In addition, morin activated CA enzyme in the liver tissue while inhibiting CA enzyme in the brain, heart and testis tissues. Morin activated 6PGD enzyme activity while it inhibited TrxR enzyme in all the tissues. Conclusion: The findings showed that doxorubicin and morin had similar properties in the tissues as to their effect on enzyme activities.

🔖

Cite This Article

Kandemir, F. M., Kucukler, S., Kuzu, M., Caglayan, C., Aggul, A. G. (2022). Alterations in Enzyme Activity of Carbonic Anhydrase, 6-phosphogluconate Dehydrogenase and Thioredoxin Reduc- tase in Rats Exposed to Doxorubicin and Morin. Clinical and Experimental Health Sciences, Cilt: 10 - Sayı: 3, 228–234. https://ajindex.com/articles/474270

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Schomburg I, Chang A and Schomburg, D. BRENDA, enzyme data and metabolic information. Nucleic Acids Res 2002; 30(1): 47-49
  2. Sarioglu N, Bilen C, Sackes Z, Gencer N. The effects of bronchodilator drugs and antibiotics used for respiratory infection on human erythrocyte carbonic anhydrase I and II isozymes. Arch Physiol Biochem 2015; 121(2): 56-61
  3. Li S, An L, Duan Q, Araneta MF, Johnson CS, Shen J. Determining the rate of carbonic anhydrase reaction in the human brain. Sci Rep 2018; 8(1): 2328
  4. Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic Anhydrases: Current State of the Art, TherapeuticApplications and Future Prospects. J Enzyme Inhib Med Chem 2004; 19(3): 199-229
  5. Erzengin Z, Bilen C, Ergun A, Gencer N. Antipsychotic agents screened as human carbonic anhydrase I and II inhibitors. Arch Physiol Biochem 2014; 120(1): 29-33
  6. Güleç Ö, Arslan M, Gencer N, Ergun A, Bilen C, Arslan O. Synthesis and carbonic anhydrase inhibitory properties of new spiroindoline-substituted sulphonamide compounds. Arch Physiol Biochem 2017; 123(5): 306-312
  7. Bayindir S, Temel Y, Ayna A, Ciftci M. The synthesis of N- benzoylindoles as inhibitors of rat erythrocyte glucose-6- phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. J Biochem Mol Toxic 2018; 32(9): e22193
  8. Ma L and Cheng Q. Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming. Biochem Biophys Res Commun 2018; 498(4): 912-917
  9. Sarfraz I, Rasul A, Hussain G, Shah MA, Zahoor AF, Asrar M, Selamoglu Z, Ji X, Adem Ş, Sarker SD. 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance. BioFactors 2020; 1-13
  10. Shan C, Elf S, Ji Q, Kang HB, Zhou L, Hitosugi T, Xie J. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. Mol Cell 2014; 55(4): 552-565
  11. Zou Q, Chen YF, Zheng XQ, Ye SF, Xu BY, Liu YX, Zeng HH. Novel thioredoxin reductase inhibitor butaselen inhibits tumorigenesis by down-regulating programmed death-ligand 1 expression. J Zhejiang Univ Sci B 2018; 19(9): 689-698
  12. Tuladhar A, Hondal RJ, Colon R, Hernandez EL, Rein KS. Effectors of thioredoxin reductase: Brevetoxins and manumycin-A. Comp Biochem Phys C 2019; 217: 76-86
  13. Lillig CH and Holmgren A. Thioredoxin and related molecules– from biology to health and disease. Antioxid Redox Sign